65,437 trials
Syncope, Vasovagal
Primary: Percentage of Participants Who Have Hypotensive Syncope or Near Syncope With SBP Less Than or Equal to 70 mmHG During Tilt Test — 32; 27; 33; 35 Participants — p=0.521
HIV · Cancer
Primary: Best Response During the Treatment Period — 1; 3; 5; 7 participants
Rotator Cuff Tear
Primary: Western Ontario Rotator Cuff Index — 72.9; 79.9 score on a scale (0-100)
Covid19
Primary: Flow Mediated Dilation of the Brachial Artery — 6.1; 6.2 % of brachial artery dilation
Gulf War · Fatigue · Pain
Primary: Short Form McGill Pain Questionnaire (SF-MPQ-2) Total Score — 69.2; 64.9; 62.3; 55.5 score on scale
Liver Cancer
Primary: CO Output (Ppm) — 2.03 ppm
Myelopathy Cervical · Kyphosis Post Surgical · Neck Pain
Primary: C2-C7 Lordosis — 11.0; 10.9 °
Myelodysplastic Syndromes
Primary: Number of Participants With Receipt of Second Transfusion
COVID-19
Primary: Proportion of Participants With Adverse Reactions — 59; 30; 39 Participants
HRAS Gene Mutation · HNSCC
Primary: Objective Response Rate (ORR) in High Variable Allele Frequency (VAF) Population, as Assessed by Independent Review Facility (IRF) — 20.0 percentage of participants
Crohn's Disease · Ulcerative Colitis
Primary: Number of Participants With Treatment Emergent Adverse Events (TEAEs) — 67; 122; 203; 4 Participants
Aging
Primary: Net Metabolic Rate (Watts/kg) — 3.30; 3.47; 3.86; 4.18 watts/kg — p=<0.001
Lower Extremity Amputation
Primary: Difference Between Investigational Foot and Usual Foot in the Prosthetic Evaluation Questionnaire (PEQ): Ambulation Sub-Scale — 4.2 score on a scale — p=0.092
Ileus · Post-Operative Adhesions
Primary: Change From Baseline in Extent and Severity of Intra-abdominal Adhesions Among Subjects Treated With LB1148 or Placebo — 20.3; 4.3; 4.0; 8.5 total extent and severity…
Healthy
Primary: Percent Change in Forearm Glucose Uptake — -73; 127; -95 Percent change in clamp FGU with immob